Molecular Cancer

official impact factor 3.78

Open Access Editorial

Frequently asked questions about Molecular Cancer

Karsta Lüttich1, Christian Schmidt2,3* and Guido M Sclabas3

Author Affiliations

1 Department of Dermatology, Weill Medical College of Cornell University, 1300 York Avenue, New York, New York, 10021, USA

2 Editor-in-Chief, Molecular Cancer, BioMed Central Ltd, Middlesex House, 34–42 Cleveland Street, London W1T 4LB, UK

3 Department of Surgical Oncology and Molecular Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA

For all author emails, please log on.

Molecular Cancer 2003, 2:16 doi:10.1186/1476-4598-2-16

Published: 31 January 2003

Abstract

Molecular Cancer is as a forum for cutting edge cancer-related papers. This editorial will answer frequently asked question about this open-access and on-line journal as well as its publisher BioMed Central.